Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma. (Q47849614)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Phase II trial of antiepidermal growth factor receptor antibody C225 in patients with advanced renal cell carcinoma. (English)

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

phase II clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

6

object named as

Jose Baselga

1 reference

Europe PubMed Central

6 February 2018

7

object named as

Hyman Muss

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

author name string

Robert Amato

2

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Mary Todd

3

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Wen-J Poo Hwu

4

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Roger Cohen

5

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Michael Cooper

8

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Richard Yu

9

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Michelle S Ginsberg

10

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Michael Needle

11

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

publication date

1 February 2003

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Investigational New Drugs

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

21

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

1

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

99-101

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

https://scigraph.springernature.com/pub.10.1023/a:1022928612511

0 references

Epidermal growth factor receptor inhibition by a monoclonal antibody as anticancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12795534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12795534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12795534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic therapy for renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/12795534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/12795534

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1023/A:1022928612511

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

6 February 2018

http://europepmc.org/abstract/MED/12795534

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47849614&oldid=1540198432"